Pharmaceuticals (Jul 2022)

Fully Automated, High-Dose Radiosynthesis of [<sup>18</sup>F]PARPi

  • Anna Pacelli,
  • Fadi Zarrad,
  • Corentin Warnier,
  • Thibault Gendron,
  • Muhammad Otabashi,
  • Charles Vriamont,
  • Alex Jackson,
  • Wolfgang P. Fendler,
  • Ken Herrmann,
  • Michael Nader

DOI
https://doi.org/10.3390/ph15070865
Journal volume & issue
Vol. 15, no. 7
p. 865

Abstract

Read online

[18F]PARPi is currently undergoing clinical trials as a PET tracer for many applications. However, only manual radiosynthesis was reported; this has several drawbacks, including an increased risk of contamination from the operator, and the need to limit the starting activity. The automation of the previously reported protocol for [18F]PARPi synthesis is challenging, as it requires transferring microvolumes of reagents, which many platforms cannot accommodate. We report a revised, high yield, and automated protocol for the radiosynthesis of [18F]PARPi, with final doses of over 20 GBq.

Keywords